P02754 (LACB_BOVIN) Bos taurus (Bovine)
Beta-lactoglobulin UniProtKBInterProSTRINGInteractive Modelling
178 aa; Sequence (Fasta) ;
1 identical sequence: Bos indicus x Bos taurus: A0A4W2BVI6
It is possible new templates exist for this target since these models were created.
Available Structures
97 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of a Recombinant IgE Fab Fragment in Complex with Bovine Beta-Lactoglobulin Aller… |
Heteromer | 100 | 2×LMT; | |||
| Bovine beta-lactoglobulin complex with myristic acid | homo-2-mer | 100.0 | 2×MYR; 2×GOL; | |||
| Bovine beta-lactoglobulin variant A at pH 4.0 | homo-2-mer | 98.77 | 2×NO3; | |||
| Bovine beta-lactoglobulin complex with linoleic acid | homo-2-mer | 100.0 | 2×EIC; 2×GOL; 2×EOH; | |||
| Bovine beta-lactoglobulin complex with stearic acid | homo-2-mer | 100.0 | 2×STE; 6×EOH; | |||
| Bovine beta-lactoglobulin (isoform A) in complex with dodecyltrimethylammonium (DTAC) | homo-2-mer | 98.73 | 2×CAT; | |||
| Engineered beta-lactoglobulin: variant L58F | homo-2-mer | 98.09 | 2×ACT; | |||
| Bovine beta-lactoglobulin (isoform B) in complex with dodecyltrimethylammonium (DTAC) | homo-2-mer | 100.0 | 2×CAT; 2×GOL; | |||
| Bovine beta-lactoglobulin complex with tetracaine (BLG-TET) | homo-2-mer | 100.0 | 2×TE4; | |||
| Bovine beta-lactoglobulin (isoform A) in complex with lauric acid (C12) | homo-2-mer | 98.73 | 2×DAO; | |||
| 12-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULIN | homo-2-mer | 98.77 | 2×BRC; | |||
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | homo-2-mer | 98.77 | ||||
| Bovine beta-lactoglobulin (isoform B) in complex with dodecyl sulphate (SDS) | homo-2-mer | 100.0 | 2×SDS; 2×GOL; | |||
| Bovine beta-lactoglobulin (isoform A) in complex with dodecyl sulphate (SDS) | homo-2-mer | 98.73 | 2×SDS; | |||
| Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta… | homo-2-mer | 100 | 3×SDS; | |||
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | homo-2-mer | 98.77 | ||||
| Recombinant bovine beta-lactoglobulin with uncleaved N-terminal methionine (rBlgB) | homo-2-mer | 100.0 | 2×GOL; 2×MYR; 2×SIN; | |||
| Recombinant bovine beta-lactoglobulin variant L1A/I2S with endogenous ligand (sBlgB#1) | homo-2-mer | 98.73 | 2×MYR; | |||
| Bovine beta-lactoglobulin complex with dodecyl sulfate | homo-2-mer | 100.0 | 2×SDS; 2×GOL; | |||
| Mutant I56F of recombinant bovine beta-lactoglobulin in complex with tetracaine | homo-2-mer | 98.72 | 3×SO4; 1×TE4; | |||
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form | homo-2-mer | 97.47 | 2×EDO; | |||
| Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP) | homo-2-mer | 97.48 | 2×Z80; | |||
| Bovine lactoglobulin complex with decanol | homo-2-mer | 100.0 | 2×DE1; | |||
| Bovine beta-lactoglobulin complex with palmitic acid | homo-2-mer | 100.0 | 2×PLM; 6×EOH; | |||
| Trigonal form of WT recombinant bovine beta-lactoglobulin | homo-2-mer | 99.36 | 4×EDO; 2×EOH; | |||
| Bovine beta-lactoglobulin complex with lauric acid | homo-2-mer | 100.0 | 2×DAO; 2×CL; | |||
| Bovine beta-lactoglobulin complex with oleic acid | homo-2-mer | 100.0 | 2×OLA; 2×EOH; 2×GOL; | |||
| Mutant L39Y of recombinant beta-lactoglobulin in complex with endogenous ligand | homo-2-mer | 98.68 | 2×DAO; 2×CL; | |||
| Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP) | homo-2-mer | 98.1 | 2×Z80; 2×PO4; | |||
| Bovine beta-lactoglobulin complex with pramocaine crystallized from ammonium sulphate (BLG-PRM2) | homo-2-mer | 100.0 | 2×PX9; | |||
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID, TRIGONAL LATTICE Z | homo-2-mer | 100 | 2×REA; | |||
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID, TRIGONAL LATTICE Z | homo-2-mer | 100 | 2×PLM; | |||
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL, TRIGONAL LATTICE Z | homo-2-mer | 100 | 2×RTL; | |||
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE, LATTICE Z | homo-2-mer | 100 | 2×PLM; | |||
| Mutant F105A of recombinant beta-lactoglobulin in complex with endogenous ligand | homo-2-mer | 99.36 | 2×DAO; 2×SO4; | |||
| Engineered beta-lactoglobulin: variant I56F | homo-2-mer | 99.36 | 2×SO4; 4×GOL; | |||
| Mutant F105L of recombinant beta-lactoglobulin | homo-2-mer | 99.36 | 4×GOL; 2×SO4; | |||
| Engineered beta-lactoglobulin: variant F105L in complex with myristic acid | homo-2-mer | 99.35 | 2×MYR; 2×EDO; | |||
| Mutant L58F of recombinant bovine beta-lactoglobulin in complex with tetracaine | homo-2-mer | 99.35 | 2×TE4; 2×SO4; | |||
| Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with pramocaine | homo-2-mer | 98.69 | 2×PX9; 2×SO4; | |||
| Mutant L58F of recombinant bovine beta-lactoglobulin in complex with pramocaine | homo-2-mer | 99.35 | 2×PX9; 2×SO4; | |||
| Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with endogenous fatty acid | homo-2-mer | 98.69 | 2×DAO; 4×EDO; 2×SO4; 2×CL; | |||
| Engineered beta-lactoglobulin: variant M107L in complex with myristic acid | homo-2-mer | 99.35 | 2×MYR; | |||
| Bovine beta-lactoglobulin crystallized in the presence of 2 mM zinc chloride | homo-2-mer | 100 | 4×ZN; | |||
| Mutant L39K of recombinant beta-lactoglobulin in complex with endogenous ligand | homo-2-mer | 99.33 | 2×DKA; 2×EDO; | |||
| Beta-lactoglobulin (low humidity) | homo-2-mer | 98.75 | ||||
| Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligand | homo-2-mer | 99.33 | 2×PLM; 6×EDO; | |||
| Mutant L39Y of recombinant bovine beta-lactoglobulin in complex with pramocaine | homo-2-mer | 99.32 | 2×PX9; 2×SO4; 2×CL; | |||
| Engineered beta-lactoglobulin: variant I56F-L39A in complex with chlorpromazine (LG-FA-CLP) | homo-2-mer | 98.72 | 2×Z80; | |||
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) | homo-2-mer | 98.08 | 2×EDO; 3×DSM; 2×SO4; 2×CL; | |||
| Engineered beta-lactoglobulin: variant I56F-L39A-M107F in complex with chlorpromazine (LG-FAF-CLP) | homo-2-mer | 98.06 | 2×Z80; 2×SO4; 2×GOL; 2×PO4; 2×CL; | |||
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) | homo-2-mer | 98.1 | 4×DSM; 1×GOL; 1×CL; 1×EDO; 2×SO4; | |||
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) | homo-2-mer | 98.08 | 1×SO4; 4×DSM; 1×CL; 2×EDO; | |||
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form | homo-2-mer | 98.03 | 1×SO4; | |||
| Bovine beta-lactoglobulin crystallized in the presence of 20 mM zinc chloride | homo-2-mer | 100 | 6×ZN; | |||
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) | homo-2-mer | 98.1 | 2×DSM; 2×EDO; 4×SO4; 6×CL; | |||
| Mutant M107L of recombinant bovine beta-lactoglobulin in complex with tetracaine | homo-2-mer | 99.35 | 2×TE4; | |||
| The Cys121Ser Mutant of Beta-Lactoglobulin | homo-2-mer | 98.1 | ||||
| Engineered beta-lactoglobulin: variant M107L | homo-2-mer | 99.31 | 2×GOL; 1×PO4; | |||
| Bovin Beta-lactoglobulin binding with zinc ions | homo-2-mer | 100 | 6×ZN; | |||
| Recombinant bovine beta-lactoglobulin variant L1A/I2S (sBlgB#2) | homo-2-mer | 98.66 | ||||
| The structure of bovine B-lactoglobulin A in crystals grown at very low ionic strength | homo-2-mer | 98.72 | ||||
| HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORM A) | homo-2-mer | 98.68 | ||||
| HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBI… | homo-2-mer | 100 | ||||
| Beta-lactoglobulin (native) | homo-2-mer | 98.68 | ||||
| Engineered beta-lactoglobulin: variant F105L | homo-2-mer | 97.76 | ||||
| Beta-lactoglobulin (reverse native) | homo-2-mer | 98.68 | ||||
| Crystal structure of Gyuba, a patched chimera of b-lactglobulin | homo-2-mer | 100 | ||||
| Bovine beta-lactoglobulin complex with capric acid | monomer | 100 | 1×DKA; 1×GOL; 1×CL; | |||
| Bovine beta-lactoglobulin complex with caprylic acid | monomer | 100 | 1×OCA; 1×CL; | |||
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | monomer | 100 | 1×TDA; | |||
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | monomer | 100 | 1×F15; 1×CL; | |||
| Bovine beta-lactoglobulin complex with pramocaine crystallized from sodium citrate (BLG-PRM1) | monomer | 100.0 | 1×PX9; | |||
| Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 18 h of soaking | monomer | 99.38 | 1×NH3; 1×PT; | |||
| Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soaking | monomer | 100 | 1×NH3; 2×PT; | |||
| Bovine beta lactoglobulin unliganded form | monomer | 100 | ||||
| STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOG… | monomer | 100 | ||||
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | monomer | 100 | 1×EW8; | |||
| Bovine beta-lactoglobulin complex with myristic acid at high pressure (0.55 GPa) | monomer | 100 | 1×MYR; | |||
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | monomer | 98.77 | ||||
| Crystal structure of beta-lactoglobulin complexed with chloroquine | monomer | 98.77 | 1×0TX; | |||
| Bovine beta-lactoglobulin complex with myristic acid, ambient pressure | monomer | 100 | 1×MYR; | |||
| Unliganded form of bovine beta-lactoglobulin, ambient pressure | monomer | 100 | 1×CL; | |||
| Bovine beta-lactoglobulin complex with dodecane at high pressure (0.43 GPa) | monomer | 100 | 1×D12; 1×CL; | |||
| Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta… | monomer | 100.0 | 1×SDS; | |||
| Beta-lactoglobulin in complex with Cp*Rh(III)Cl N,N-di(pyridin-2-yl)dodecanamide | monomer | 98.72 | 1×RHL; | |||
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | monomer | 100 | 1×X90; | |||
| Crystal structure of a secondary vitamin D3 binding site of milk beta-lactoglobulin | monomer | 100 | 2×VD3; | |||
| Bovine beta lactoglobulin crytsallized through ligandation of yttrium | monomer | 100 | 2×YT3; 2×CL; | |||
| X.ray structure of the oxaliplatin/beta-lactoglobulin adduct | monomer | 100 | 1×PT; | |||
| Engineered beta-lactoglobulin: variant L58F in complex with myristic acid | monomer | 99.32 | 1×MYR; 1×SO4; | |||
| The structure of bovine beta-lactoglobulin in novel crystals grown at pH 3.8 | monomer | 100 | 1×CA; | |||
| BOVINE BETA-LACTOGLOBULIN A | monomer | 98.75 | ||||
| STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMER | monomer | 98.75 | ||||
| Bovine beta lactoglobulin crystallized through ligandation of yttrium cations | monomer | 100 | 2×YT3; 2×CL; | |||
| Crystal structure of dha bind to bovine beta-lactoglobulin | monomer | 100 | ||||
| BOVINE BETA-LACTOGLOBULIN, LATTICE X | monomer | 99.36 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6nkq.1.A | monomer | 0.86 | 1×CA; | 100.00 | ||